Literature DB >> 3572430

Central motor conduction is abnormal in motor neuron disease.

D A Ingram, M Swash.   

Abstract

Conduction in the central motor pathways of the brain and spinal cord was studied in 12 patients with motor neuron disease. Six healthy volunteers served as controls. Transcutaneous electrical stimulation of the cortex, cervical cord, thoracic cord and conus medullaris was used to determine motor latencies to the biceps brachii, thenar eminence and tibialis anterior muscles. Prominent, and often asymmetrical, slowing of central motor conduction was demonstrated in seven of the 12 patients; these findings were most marked in the spinal cord and in most cases correlated with clinical features of corticospinal involvement. In general it was more difficult to excite motor pathways in the central nervous system in the patients with motor neuron disease than in control subjects. Evidence of subclinical involvement of central motor pathways was found in five patients. The central lesion in motor neuron disease may thus contribute more significantly to the clinical deficit than has been realised, since the clinical signs of the upper motor neuron lesion are often masked by the more obvious lower motor neuron features.

Entities:  

Mesh:

Year:  1987        PMID: 3572430      PMCID: PMC1031487          DOI: 10.1136/jnnp.50.2.159

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  11 in total

1.  Frequency of nerve fiber degeneration of peripheral motor and sensory neurons in amyotrophic lateral sclerosis. Morphometry of deep and superficial peroneal nerves.

Authors:  P J Dyck; J C Stevens; D W Mulder; R E Espinosa
Journal:  Neurology       Date:  1975-08       Impact factor: 9.910

2.  The central nervous system in motor neurone disease.

Authors:  B Brownell; D R Oppenheimer; J T Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-06       Impact factor: 10.154

3.  Abnormalities in central motor pathway conduction in multiple sclerosis.

Authors:  J M Cowan; J C Rothwell; J P Dick; P D Thompson; B L Day; C D Marsden
Journal:  Lancet       Date:  1984-08-11       Impact factor: 79.321

4.  Scope of a technique for electrical stimulation of human brain, spinal cord, and muscle.

Authors:  P A Merton; D K Hill; H B Morton; C D Marsden
Journal:  Lancet       Date:  1982-09-11       Impact factor: 79.321

5.  Spinal and far-field components of human somatosensory evoked potentials to posterior tibial nerve stimulation analysed with oesophageal derivations and non-cephalic reference recording.

Authors:  J E Desmedt; G Cheron
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1983-12

6.  Direct electrical stimulation of corticospinal pathways through the intact scalp in human subjects.

Authors:  C D Marsden; P A Merton; H B Morton
Journal:  Adv Neurol       Date:  1983

7.  Inhibition of terminal axonal sprouting by serum from patients with amyotrophic lateral sclerosis.

Authors:  M E Gurney; A C Belton; N Cashman; J P Antel
Journal:  N Engl J Med       Date:  1984-10-11       Impact factor: 91.245

8.  Stimulation of the cerebral cortex in the intact human subject.

Authors:  P A Merton; H B Morton
Journal:  Nature       Date:  1980-05-22       Impact factor: 49.962

9.  Degeneration and regeneration of ventral root motor fibers in amyotrophic lateral sclerosis. Morphometric studies of cervical ventral roots.

Authors:  N Hanyu; K Oguchi; N Yanagisawa; H Tsukagoshi
Journal:  J Neurol Sci       Date:  1982-07       Impact factor: 3.181

10.  Motor conduction velocity in the human spinal cord: slowed conduction in multiple sclerosis and radiation myelopathy.

Authors:  S J Snooks; M Swash
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-11       Impact factor: 10.154

View more
  16 in total

1.  Central motor and sensory conduction in X-linked recessive bulbospinal neuronopathy.

Authors:  T Kachi; G Sobue; I Sobue
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-05       Impact factor: 10.154

2.  Central motor conduction in a family with hereditary motor and sensory neuropathy with pyramidal signs (HMSN V).

Authors:  A Schnider; C W Hess; S Koppi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-06       Impact factor: 10.154

3.  Central motor conduction studies in hereditary spastic paraplegia.

Authors:  W Schady; J P Dick; A Sheard; S Crampton
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-09       Impact factor: 10.154

4.  Motor potentials of bulbocavernosus muscle after transcranial and lumbar magnetic stimulation: comparative study with bulbocavernosus reflex and pudendal evoked potentials.

Authors:  A Ghezzi; L Callea; M Zaffaroni; R Montanini; G Tessera
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-06       Impact factor: 10.154

5.  High-voltage stimulation over the human spinal cord: sources of latency variation.

Authors:  B L Plassman; S C Gandevia
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

6.  Preclinical and subclinical events in motor neuron disease.

Authors:  M Swash; D Ingram
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-02       Impact factor: 10.154

7.  Stimulation of motor tracts in multiple sclerosis.

Authors:  A Berardelli; M Inghilleri; G Cruccu; M Fornarelli; N Accornero; M Manfredi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-05       Impact factor: 10.154

8.  Optimising the detection of upper motor neuron function dysfunction in amyotrophic lateral sclerosis--a transcranial magnetic stimulation study.

Authors:  Abena D Osei-Lah; Kerry R Mills
Journal:  J Neurol       Date:  2004-11       Impact factor: 4.849

9.  Peripheral and central conduction studies in neurolathyrism.

Authors:  U K Misra; V P Sharma
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-05       Impact factor: 10.154

10.  Impairment of visual perception and visual short term memory scanning by transcranial magnetic stimulation of occipital cortex.

Authors:  G Beckers; V Hömberg
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.